Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

A study uncovers IL-1β signaling in cardiac fibrosis, highlighting distinct fibroblast populations and promising ...

Secukinumab is safe and effective over a 48-month period among patients with PsA, demonstrating sustained disease control and high drug retention rates.

In Australia, chronic pain affects 3.4 million Australians. Around 68 per cent of people living with chronic pain are of ...

Welcome to Ask Doctor Zac, a weekly column from news.com.au. This week, Dr Zac Turner explores the truth behind pain relief.

US FDA approves UCB’s 320 mg single-injection device presentations of Bimzelx: Brussels, Belgium Tuesday, October 15, 2024, 13:00 Hrs [IST] UCB, a global biopharmaceutical compa ...

Here are some strategies for potentially preventing arthritis: Maintain a Healthy Weight: Many cases of arthritis can be ...

World Arthritis Day, observed on October 12 each year, plays a crucial role in raising awareness about the millions of people ...

Piclidenoson, an orally administered drug, has demonstrated a safety and efficacy profile in a Phase III trial for psoriasis ...

However, in rheumatoid arthritis (RA) – a chronic and progressive autoimmune disease – the immune system doesn’t work properly and attacks the lining of the joints instead, causing pain and ...

Back pain is one of the most common causes for which patients visit doctors. In some individuals it tends to be persistent, ...

The global ankylosing spondylitis treatment market is witnessing significant growth, with projections indicating a market value of USD 8.06 billion in 2022 and an expected increase to USD 5.1409 ...